Information Provided By:
Fly News Breaks for July 23, 2015
BSX
Jul 23, 2015 | 15:27 EDT
BofA/Merrill would use Boston Scientific weakness as a buying opportunity and notes the pipeline is strong heading into 2H. The firm rates shares a Buy with a $21 price target.